Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.52 USD | -0.27% | +1.26% | -17.68% |
Apr. 23 | Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe | MT |
Apr. 18 | Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.68% | 10.01B | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne, Thermo Fisher Scientific in Agreement to Develop, Commercialize Kidney Transplant Rejection Test ExoTRU